                         SEQUENCE LISTING

<110>  Stemguard A/S
 
<120>  NOVEL IMMUNOSTIMULATING PEPTIDES

<130>  21159PCT00

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Homo sapiens

<400>  1

Leu Gln Asn Arg Arg Gly Leu Gly Leu Ser Ile Leu Leu Asn Glu Glu 
1               5                   10                  15      


Cys 
    


<210>  2
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence

<400>  2

Leu Gln Asn Arg Arg Gly Leu Gly Leu Ser Ile Leu Leu Asn Cys 
1               5                   10                  15  


<210>  3
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence

<400>  3

Leu Gln Asn Lys Arg Gly Leu Gly Leu Ser Ile Leu Leu Asn Glu Glu 
1               5                   10                  15      


Cys Gly Pro Gly Pro Gly Pro 
            20              


<210>  4
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence

<400>  4

Leu Gln Asn Arg Arg Gly Leu Gly Leu Ser Ile Leu Leu Asn Glu Glu 
1               5                   10                  15      


<210>  5
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence

<400>  5

Leu Gln Asn Arg Arg Gly Leu Gly Leu Ser Ile Leu Leu Asn Glu Glu 
1               5                   10                  15      


Leu Gln Asn Arg Arg Gly Leu 
            20              


<210>  6
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence

<400>  6

Leu Gln Asn Lys Arg Gly Leu Gly Leu Ser Ile Leu Leu Asn Cys 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence

<400>  7

Leu Gln Asn Lys Lys Gly Leu Gly Leu Ser Ile Leu Leu Asn Cys 
1               5                   10                  15  


<210>  8
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Mutated sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Xaa is Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (15)..(16)
<223>  Xaa is Glu or absent

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is Cys or absent

<400>  8

Leu Gln Asn Xaa Xaa Gly Leu Gly Leu Ser Ile Leu Leu Asn Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  9
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  9

Gly Leu Ser Ile Leu Leu Asn Glu Glu 
1               5                   


<210>  10
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Env 59 derived peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Leu or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Gln or absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Asn or absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Arg or Lys or absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Arg or Lys or absent

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Gly or absent

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is Leu or absent

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Glu or absent

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is Glu or absent

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is Cys or absent

<400>  10

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Gly Leu Ser Ile Leu Leu Asn Xaa Xaa 
1               5                   10                  15      


Xaa 
    


<210>  11
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Gly-Pro repeat

<400>  11

Cys Gly Pro Gly Pro Gly Pro 
1               5           


<210>  12
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  GP repeat

<400>  12

Gly Pro Gly Pro Gly Pro 
1               5       


